Botulinum Toxin Type A in the Treatment of Chronic Anal Fissure (NCT05598164) | Clinical Trial Compass
UnknownNot Applicable
Botulinum Toxin Type A in the Treatment of Chronic Anal Fissure
Russia140 participantsStarted 2022-09-01
Plain-language summary
This study is aimed at studying the effectiveness and safety of surgical treatment of chronic anal fissure.
Who can participate
Age range18 Years – 70 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients with chronic anal fissure with spasm of anal sphincter
Exclusion Criteria:
* Inflammatory diseases of the colon
* Pectenosis
* Previous surgical interventions on the anal canal
* IV grade internal and external hemorrhoids
* Rectal fistula
* Severe somatic diseases at the decompensation stage
* Pregnancy and lactation
* Anal sphincter insufficiency
* Chronic paraproctitis
* Fibrous polyp of the anal canal, accompanied by clinical manifestations
* Individual intolerance and hypersensitivity to botulinum toxin
* Myasthenia gravis and myasthenic syndromes
What they're measuring
1
Anal sphincter insufficiency
Timeframe: Up to 60 days
Trial details
NCT IDNCT05598164
SponsorState Scientific Centre of Coloproctology, Russian Federation